ICU Medical (NASDAQ:ICUI) Cut to Hold at StockNews.com

StockNews.com cut shares of ICU Medical (NASDAQ:ICUI) from a buy rating to a hold rating in a research note issued to investors on Thursday.

A number of other brokerages have also commented on ICUI. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a report on Wednesday, December 11th. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $168.67.

ICU Medical Stock Down 2.9 %

ICU Medical stock opened at $140.16 on Thursday. The company’s 50-day moving average price is $154.42 and its two-hundred day moving average price is $163.82. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.44 billion, a P/E ratio of -30.67 and a beta of 0.73. ICU Medical has a twelve month low of $93.36 and a twelve month high of $196.26.

Insider Transactions at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,262,119.64. This represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 6.70% of the stock is currently owned by insiders.

Institutional Trading of ICU Medical

Several institutional investors and hedge funds have recently modified their holdings of the business. Barclays PLC raised its stake in ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after acquiring an additional 8,010 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in shares of ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after acquiring an additional 25,031 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in shares of ICU Medical by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock valued at $2,258,000 after acquiring an additional 6,981 shares in the last quarter. Jennison Associates LLC bought a new stake in ICU Medical during the 4th quarter worth $556,000. Finally, Geode Capital Management LLC increased its holdings in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after purchasing an additional 48,106 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.